bepridil has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldoni, S | 1 |
| Del Papa, B | 1 |
| Dorillo, E | 1 |
| Aureli, P | 1 |
| De Falco, F | 1 |
| Rompietti, C | 1 |
| Sorcini, D | 1 |
| Varasano, E | 1 |
| Cecchini, D | 1 |
| Zei, T | 1 |
| Di Tommaso, A | 1 |
| Rosati, E | 1 |
| Alexe, G | 1 |
| Roti, G | 1 |
| Stegmaier, K | 1 |
| Di Ianni, M | 1 |
| Falzetti, F | 1 |
| Sportoletti, P | 1 |
1 other study available for bepridil and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bepridil; Biomarkers, Tumor; Calcium Channel Blockers; Ch | 2018 |